#stock-upgrade

[ follow ]
Healthcare
from24/7 Wall St.
2 days ago

Why Raymond James Says Wall Street Is Underestimating UnitedHealth's Earnings Power

Raymond James upgraded UnitedHealth Group to Outperform, citing potential earnings upside and margin improvement at Optum Health.
Business
from24/7 Wall St.
2 days ago

Disney Receives Upgrade and Is Historically Cheap Even in Harsh Scenarios

Raymond James upgraded Disney's rating to Outperform, citing attractive entry points for long-term investors amid a 13.06% year-to-date stock decline.
Business
from24/7 Wall St.
2 days ago

DA Davidson Upgrades Rivian From Underperform - Here's What Still Has to Go Right

DA Davidson upgraded Rivian Automotive to Neutral from Underperform, citing valuation after a significant stock pullback.
from24/7 Wall St.
3 days ago

Wall Street Back on the Burger Train

Senatore cited menu innovation and featured value as contributing to more stable same-store traffic. On the cost side, supply-chain savings are offsetting inflation, allowing BofA to raise its FY26 adjusted EBITDA estimate to $288M from $279M.
Business
Business
from24/7 Wall St.
3 days ago

Emerson Electric Receives Wall Street Upgrade to Buy and Price Target to $175

Jefferies upgraded Emerson Electric to Buy, citing strong order momentum and earnings growth potential.
from24/7 Wall St.
3 days ago

Wall Street Thinks Western Digital Stock Price Will Soar Higher This Year

Bernstein's analysis suggests that the recent selloff creates an attractive entry point for investors, emphasizing that TurboQuant should have 'zero impact' on hard disk drive demand and 'negligible impact' on NAND demand.
Tech industry
Business
from24/7 Wall St.
1 week ago

TripAdvisor Receives Bank of America Upgrade to Buy

Bank of America upgraded TripAdvisor to Buy, citing Starboard Value's board involvement and a strategic review of TheFork as catalysts for value realization.
Business
from24/7 Wall St.
1 week ago

Phathom Pharmaceuticals Upgraded by Barclays to Overweight With $18 Target

Barclays upgraded Phathom Pharmaceuticals to Overweight, raising the price target to $18, citing an attractive entry point ahead of expected revenue growth.
from24/7 Wall St.
1 week ago

Nucor Was Just Upgraded to Buy by UBS With $190 Price Target

UBS analyst Andrew Jones upgraded Nucor Corp to Buy from Neutral, raising the price target to $190 from $184, citing a recent pullback as a compelling entry point.
Business
from24/7 Wall St.
1 week ago

Wall Street Turns Less Bearish on Airbnb: Truist Raises Target to $129

Truist's upgrade centers on improving profitability expectations. The firm raised its 2026 adjusted EBITDA estimates for Airbnb after Q4 results showed the company's investment cycle beginning to stabilize.
Real estate
from24/7 Wall St.
3 weeks ago

Rivian's Future Rides on April's R2 Launch

TD Cowen's Itay Michaeli believes significant sales uptake for the R2 will far exceed what Wall Street is currently modeling, potentially unlocking profitability and sending shares higher. He forecasts full-scale U.S. demand for the model in the range of 212,000 to 335,000 units annually once production hits stride. That range sits well above consensus estimates and could drive meaningful upside to 2027 revenue and EBITDA forecasts.
Cars
[ Load more ]